

With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare.Ìý
Highlights
The global Direct-to-Consumer Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Direct-to-Consumer Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Direct-to-Consumer Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Direct-to-Consumer Testing in Doctor Office is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Direct-to-Consumer Testing include 23andMe, deCODEme, DNA DTC, GeneByGene, Genecodebook Oy, Genetrainer, MD Revolution, Myriad Genetics and Navigenics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Direct-to-Consumer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct-to-Consumer Testing.
The Direct-to-Consumer Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Direct-to-Consumer Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Direct-to-Consumer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
23andMe
deCODEme
DNA DTC
GeneByGene
Genecodebook Oy
Genetrainer
MD Revolution
Myriad Genetics
Navigenics
Segment by Type
Routine Clinical Laboratory Testing
Medical Genetic Laboratory Testing
Segment by Application
Doctor Office
Internet
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Direct-to-Consumer Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct-to-Consumer Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Routine Clinical Laboratory Testing
1.2.3 Medical Genetic Laboratory Testing
1.3 Market by Application
1.3.1 Global Direct-to-Consumer Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Doctor Office
1.3.3 Internet
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Direct-to-Consumer Testing Market Perspective (2018-2029)
2.2 Direct-to-Consumer Testing Growth Trends by Region
2.2.1 Global Direct-to-Consumer Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Direct-to-Consumer Testing Historic Market Size by Region (2018-2023)
2.2.3 Direct-to-Consumer Testing Forecasted Market Size by Region (2024-2029)
2.3 Direct-to-Consumer Testing Market Dynamics
2.3.1 Direct-to-Consumer Testing Industry Trends
2.3.2 Direct-to-Consumer Testing Market Drivers
2.3.3 Direct-to-Consumer Testing Market Challenges
2.3.4 Direct-to-Consumer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Direct-to-Consumer Testing Players by Revenue
3.1.1 Global Top Direct-to-Consumer Testing Players by Revenue (2018-2023)
3.1.2 Global Direct-to-Consumer Testing Revenue Market Share by Players (2018-2023)
3.2 Global Direct-to-Consumer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Direct-to-Consumer Testing Revenue
3.4 Global Direct-to-Consumer Testing Market Concentration Ratio
3.4.1 Global Direct-to-Consumer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct-to-Consumer Testing Revenue in 2022
3.5 Direct-to-Consumer Testing Key Players Head office and Area Served
3.6 Key Players Direct-to-Consumer Testing Product Solution and Service
3.7 Date of Enter into Direct-to-Consumer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Direct-to-Consumer Testing Breakdown Data by Type
4.1 Global Direct-to-Consumer Testing Historic Market Size by Type (2018-2023)
4.2 Global Direct-to-Consumer Testing Forecasted Market Size by Type (2024-2029)
5 Direct-to-Consumer Testing Breakdown Data by Application
5.1 Global Direct-to-Consumer Testing Historic Market Size by Application (2018-2023)
5.2 Global Direct-to-Consumer Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Direct-to-Consumer Testing Market Size (2018-2029)
6.2 North America Direct-to-Consumer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Direct-to-Consumer Testing Market Size by Country (2018-2023)
6.4 North America Direct-to-Consumer Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Direct-to-Consumer Testing Market Size (2018-2029)
7.2 Europe Direct-to-Consumer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Direct-to-Consumer Testing Market Size by Country (2018-2023)
7.4 Europe Direct-to-Consumer Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Direct-to-Consumer Testing Market Size (2018-2029)
8.2 Asia-Pacific Direct-to-Consumer Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Direct-to-Consumer Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Direct-to-Consumer Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Direct-to-Consumer Testing Market Size (2018-2029)
9.2 Latin America Direct-to-Consumer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Direct-to-Consumer Testing Market Size by Country (2018-2023)
9.4 Latin America Direct-to-Consumer Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Direct-to-Consumer Testing Market Size (2018-2029)
10.2 Middle East & Africa Direct-to-Consumer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Direct-to-Consumer Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Direct-to-Consumer Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Direct-to-Consumer Testing Introduction
11.1.4 23andMe Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.1.5 23andMe Recent Development
11.2 deCODEme
11.2.1 deCODEme Company Detail
11.2.2 deCODEme Business Overview
11.2.3 deCODEme Direct-to-Consumer Testing Introduction
11.2.4 deCODEme Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.2.5 deCODEme Recent Development
11.3 DNA DTC
11.3.1 DNA DTC Company Detail
11.3.2 DNA DTC Business Overview
11.3.3 DNA DTC Direct-to-Consumer Testing Introduction
11.3.4 DNA DTC Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.3.5 DNA DTC Recent Development
11.4 GeneByGene
11.4.1 GeneByGene Company Detail
11.4.2 GeneByGene Business Overview
11.4.3 GeneByGene Direct-to-Consumer Testing Introduction
11.4.4 GeneByGene Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.4.5 GeneByGene Recent Development
11.5 Genecodebook Oy
11.5.1 Genecodebook Oy Company Detail
11.5.2 Genecodebook Oy Business Overview
11.5.3 Genecodebook Oy Direct-to-Consumer Testing Introduction
11.5.4 Genecodebook Oy Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.5.5 Genecodebook Oy Recent Development
11.6 Genetrainer
11.6.1 Genetrainer Company Detail
11.6.2 Genetrainer Business Overview
11.6.3 Genetrainer Direct-to-Consumer Testing Introduction
11.6.4 Genetrainer Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.6.5 Genetrainer Recent Development
11.7 MD Revolution
11.7.1 MD Revolution Company Detail
11.7.2 MD Revolution Business Overview
11.7.3 MD Revolution Direct-to-Consumer Testing Introduction
11.7.4 MD Revolution Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.7.5 MD Revolution Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Detail
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Direct-to-Consumer Testing Introduction
11.8.4 Myriad Genetics Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.8.5 Myriad Genetics Recent Development
11.9 Navigenics
11.9.1 Navigenics Company Detail
11.9.2 Navigenics Business Overview
11.9.3 Navigenics Direct-to-Consumer Testing Introduction
11.9.4 Navigenics Revenue in Direct-to-Consumer Testing Business (2018-2023)
11.9.5 Navigenics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
23andMe
deCODEme
DNA DTC
GeneByGene
Genecodebook Oy
Genetrainer
MD Revolution
Myriad Genetics
Navigenics
Ìý
Ìý
*If Applicable.